Item 2.02 Results of Operations and Financial Condition.

On May 11, 2023, Histogen Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2023. The full text of such press release is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall expressly be set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



Exhibit
Number    Exhibits
  99.1      Press Release, dated May 11, 2023
   104    Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                     * * *
                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses